Catalyst Wire Dossier Catalyst Wire Dossier

Ofev (nintedanib)

nintedanib · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ofev (nintedanib), covering 2025-10-10 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants [Phase 1]

See pricing